Skip Navigation

JNCI Journal of the National Cancer Institute 2007 99(7):493; doi:10.1093/jnci/djk160
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Japanese Translation
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2007.

IN THIS ISSUE

The first 10% of the full text of this article appears below.

Results from Adjuvant Breast Cancer Randomized Trials

Patients with early-stage breast cancer have an improved outcome after a single treatment with tamoxifen, ovarian ablation or suppression, or chemotherapy. The Adjuvant Breast Cancer Trials were initiated to determine whether 5 years of tamoxifen treatment, combined with chemotherapy and/or ovarian ablation or suppression, would further improve outcomes. In the chemotherapy trial reported by Bliss et al. (p. 506), 1,991 women with early-stage breast cancer were randomly assigned between 1992 and 2000 to receive chemotherapy. The women could have undergone ovarian ablation or suppression or not. The addition of . . . [Full Text of this Article]

PSA Levels and Prediction of Lethal Prostate Cancer

Noncancer Causes of Death in Testicular Cancer Survivors

Trial of Celecoxib in Patients with Barrett's Esophagus

Androgen Signals and Sex in Bladder Cancer Development


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

Adjuvant Therapy for Breast Cancer: We Are Solving the Puzzle, But Pieces Are Still Missing
Kathleen I. Pritchard
J Natl Cancer Inst 2007 99: 494-495. [Extract] [Full Text] [PDF]

Prostate-Specific Antigen Levels, Prostate-Specific Antigen Kinetics, and Prostate Cancer Prognosis: A Tocsin Calling for Prospective Studies
Dipen J. Parekh, Donna P. Ankerst, and Ian M. Thompson
J Natl Cancer Inst 2007 99: 496-497. [Extract] [Full Text] [PDF]

Polychemotherapy for Early Breast Cancer: Results From the International Adjuvant Breast Cancer Chemotherapy Randomized Trial
The Adjuvant Breast Cancer Trials Collaborative Group
J Natl Cancer Inst 2007 99: 506-515. [Abstract] [Full Text] [PDF]

Ovarian Ablation or Suppression in Premenopausal Early Breast Cancer: Results From the International Adjuvant Breast Cancer Ovarian Ablation or Suppression Randomized Trial
The Adjuvant Breast Cancer Trials Collaborative Group
J Natl Cancer Inst 2007 99: 516-525. [Abstract] [Full Text] [PDF]

Prostate-Specific Antigen Levels as a Predictor of Lethal Prostate Cancer
Katja Fall, Hans Garmo, Ove Andrén, Anna Bill-Axelson, Jan Adolfsson, Hans-Olov Adami, Jan-Erik Johansson, and Lars Holmberg
J Natl Cancer Inst 2007 99: 526-532. [Abstract] [Full Text] [PDF]

Noncancer Causes of Death in Survivors of Testicular Cancer
Sophie D. Fosså, Ethel Gilbert, Graça M. Dores, Jinbo Chen, Katherine A. McGlynn, Sara Schonfeld, Hans Storm, Per Hall, Eric Holowaty, Aage Andersen, Heikki Joensuu, Michael Andersson, Magnus Kaijser, Mary Gospodarowicz, Randi Cohen, Eero Pukkala, and Lois B. Travis
J Natl Cancer Inst 2007 99: 533-544. [Abstract] [Full Text] [PDF]

Secondary Chemoprevention of Barrett's Esophagus With Celecoxib: Results of a Randomized Trial
Elisabeth I. Heath, Marcia Irene Canto, Steven Piantadosi, Elizabeth Montgomery, Wilfred M. Weinstein, James G. Herman, Andrew J. Dannenberg, Vincent W. Yang, Albert O. Shar, Ernest Hawk, and Arlene A. Forastiere
J Natl Cancer Inst 2007 99: 545-557. [Abstract] [Full Text] [PDF]

Promotion of Bladder Cancer Development and Progression by Androgen Receptor Signals
Hiroshi Miyamoto, Zhiming Yang, Yei-Tsung Chen, Hitoshi Ishiguro, Hiroji Uemura, Yoshinobu Kubota, Yoji Nagashima, Yu-Jia Chang, Yueh-Chiang Hu, Meng-Yin Tsai, Shuyuan Yeh, Edward M. Messing, and Chawnshang Chang
J Natl Cancer Inst 2007 99: 558-568. [Abstract] [Full Text] [PDF]